Zhejiang Provincial Center for Disease Control and Prevention
Zhejiang Provincial Center for Disease Control and Prevention
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase IV Study to Evaluate the Immune Responses of Subunit Influenza Vaccine in Healthy Adults | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 4 | 2026-10-02 | NCT07854392 | |
| Childhood Infection and Immunity Longitudinal Cohort | Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not stated | 2026-09-11 | NCT07815925 | |
| Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis | Japanese Encephalitis Vaccine | Active, not recruiting | Phase 4 | 2026-09-02 | NCT06825312 | |
| Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 4 | 2026-06-11 | NCT07281677 | |
| Long-term Effectiveness of the Live Attenuated Herpes Zoster Vaccine | DNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Recruiting | Not stated | 2026-05-13 | NCT07585370 | |
| Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination | Prevention of Influenza | Not yet recruiting | Phase 3 | 2025-08-21 | NCT07133802 |